Clinical Trial Update: FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer [Phase 2]

View source ↗

Summary

This document provides an update on the Phase 2 FACILE trial evaluating first-line ribociclib in older patients with advanced breast cancer; the study (NCT03944…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• KISQALI (ribociclib)

Snippet

Sponsor: Fondazione Sandro Pitigliani | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING